Drug Profile
Research programme: allergy therapy - Novavax
Alternative Names: Allergy therapy research programme - Novavax; NX-401Latest Information Update: 06 Jul 2005
Price :
$50
*
At a glance
- Originator Novavax
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypersensitivity
Most Recent Events
- 06 Jul 2005 Preclinical trials in Allergy in USA (Topical)